EXCELINDUSExcel Industries Limited
Chemicals · Specialty Chemicals · NSE · as of 2026-10-26 (delayed ~30 min in market hours)
Excel Industries Limited engages in manufactures and sells chemicals, and environmental and biotech products and services in India and internationally. The company offers specialty chemicals, intermediates and actives catering to various end users like agrochemicals, water treatment, soaps and detergents, lube oil additives, mining chemicals, polymer additives and pharmaceuticals; and active pharmaceutical ingredients (APIs), as well as agrochemical inputs, biocides, soil and water conditioners, phosphorus pentachloride, phosphorus trichloride, and thiophosphoryl chloride. It also provides organic waste management composting, municipal solid waste management, plastic waste management, and construction and demolition waste management services. In addition, the company offers polymer input and veterinary APIs. Excel Industries Limited was founded in 1941 and is headquartered in Mumbai, India.
Price & Volume
Loading chart…
Key Ratios
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
None of the 16 pattern scanners currently detects a setup on EXCELINDUS — signals appear here automatically when one forms (checked on every data refresh). The Trade Plan on the right always provides stop-loss and target levels regardless.
Why avoid
- • Overall evidence is weak (AlgoScore 28/100)
- • Revenue growth: -5.1% YoY
- • Profit growth: -12.7% YoY
- • RSI: 29
- • MACD: bearish
Bull case
- • Debt/Equity: 0.00
- • Promoter holding: 56.6%
- • Valuation vs sector: P/E 14.9 vs sector 23.2
- • Golden cross setup: SMA50 above SMA200
Bear case
- • Revenue growth: -5.1% YoY
- • Profit growth: -12.7% YoY
- • RSI: 29
- • MACD: bearish
Key risks
- • Weak fundamentals — technical strength may not sustain
- • Momentum is fading versus the broader market
- • Revenue growth: -5.1% YoY
- • Profit growth: -12.7% YoY
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹30.69). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.